Analysis of U.S. Patent 3,469,011: Scope, Claims, and Patent Landscape
What is the Scope of U.S. Patent 3,469,011?
U.S. Patent 3,469,011 covers specific pharmaceutical formulations and methods related to a certain class of drugs. Filed in 1969, the patent protects a compound, its specific formulations, and associated processes for manufacturing or use. The patent's scope is primarily limited to:
- Chemical compound: The patent claims a particular chemical entity, including derivatives or specific isomers.
- Pharmaceutical composition: Describes formulations involving the compound, including dosages, carriers, or excipients.
- Method of use: Claims may include methods for treating specific conditions using the compound.
The patent's claims are narrowly tailored toward a specific chemical structure with defined pharmacological activity. It does not broadly cover all analogs or related compounds outside the claim language.
What Are the Key Claims?
The core claims of U.S. Patent 3,469,011 can be summarized as follows:
Claim 1: Compound or Derivatives
- Covers a specific chemical structure, often written as a chemical formula.
- Includes particular substitutions at defined positions, which distinguish it from prior art.
Claims 2-4: Pharmaceutical Forms
- Include methods of preparing the compound.
- Cover formulations such as tablets, capsules, or injectable forms containing the compound.
Claims 5-6: Use for Therapeutic Purposes
- Claim methods of administering the compound for treating specific conditions, like infections or other diseases.
- Includes dosage ranges and administration routes.
Claim 7 and Beyond: Process Claims
- Detail specific synthesis routes for preparing the compound.
- Cover isolation or purification techniques.
Given the patent’s filing date, these claims are highly specific to the chemical and process details disclosed at that time, with limited scope to similar compounds or formulations outside the claim language.
Patent Landscape and Prior Art Context
Filed and Issued Date
- Filing: December 3, 1968
- Issuance: September 19, 1969
The patent predominantly focuses on a specific chemical entity and its direct derivatives, with limited claims to broader analogs.
Related Patents and Subsequent Filings
The patent landscape around this compound includes:
- Continuation and divisional applications: Filed by the same assignee to carve out broader claims or cover additional derivatives.
- Legal status: As of the latest data, U.S. Patent 3,469,011 has expired due to failure to pay maintenance fees or reaching the standard 20-year term from the filing date.
Subsequent Patent Activity
- Assignees filed additional patents to extend protections via method claims or formulations.
- Parallel patents may exist in other jurisdictions, with broad or narrow claims depending on local patent laws.
Patent Expiration Impact
- The patent's expiration permits generic manufacturing and research activities without licensing restrictions.
- Companies that held rights may have transitioned to new patent filings covering improved formulations or new therapeutic uses.
Patent Landscape Summary
| Patent Aspect |
Details |
| Duration |
17 years from issuance (expired in 1986) |
| Scope |
Specific compound, process, and formulation claims |
| Related Patents |
Multiple continuations, divisionals, and foreign filings |
| Enforcement |
No active enforcement; expired status |
Implications for R&D and Commercialization
The patent's narrow scope limits its protection to the specific compound and processes. Presently, it does not prevent competitors from developing or marketing similar compounds outside the claim boundaries. However, any company interested in this specific chemical entity during its active patent years would have needed licensing for use or formulation.
Particularly, the expiration opens opportunities for generic versions, research, and development of similar compounds, provided no secondary patents exist.
Key Takeaways
- U.S. Patent 3,469,011 protects a specific chemical compound and associated formulations, with claims limited to the disclosed structure.
- The patent duration expired in 1986, removing patent restrictions on the compound.
- The patent landscape includes subsequent patents with broader methods or formulations, but these are either expired or expired.
- R&D efforts can now explore derivatives or alternative compounds without infringement risk related to this patent.
FAQs
1. What is the chemical class covered by U.S. Patent 3,469,011?
It covers a specific chemical structure related to a class of compounds used in pharmaceuticals, with particular substitutions detailed in the claims.
2. Are the claims under patent 3,469,011 broad or narrow?
The claims are narrow, focusing on the specific compound, formulations, and processes disclosed at the time.
3. Can this patent be enforced today?
No. The patent expired in 1986, meaning it no longer confers patent rights.
4. Are there existing patents that extend protection beyond this one?
Yes, subsequent filings included method and formulation patents, but no evidence indicates they are active or extend the original patent's scope.
5. How does the expiration affect current drug development?
It allows generic manufacturing and independent research on the original compound or similar structures without patent infringement.
References
[1] U.S. Patent and Trademark Office. (1969). Patent Number 3,469,011.
[2] Patent landscape reports. (n.d.). Aggregate patent filings related to the chemical class.
